[Adult non-Hodgkin bone lymphomas]

Bull Cancer. 2021 Apr;108(4):424-434. doi: 10.1016/j.bulcan.2020.12.010. Epub 2021 Mar 12.
[Article in French]

Abstract

Two forms of bone lymphomas can be distinguished: the primary bone lymphoma (PBL) and the secondary bone lymphoma (SBL). PBL is a rare disease with a good prognosis. Clinical manifestations and imaging findings are usually non-specific. Patient can present with pain, swelling of affected bone or pathologic fracture. Positron emission tomography-CT scan is a sensitive imaging modality and very useful for staging, restaging, surveillance of recurrence, and monitoring of treatment response of lymphoma. The diagnosis of PBL is often difficult and made after biopsy examination. Most patients have diffuse large B-cell lymphoma. Patients have been treated with radiotherapy, chemotherapy or combination of both. Localized disease, low IPI (International Prognostic Index) and complete remission after initial treatment were associated with a better outcome. Management of late sequelae deserves particular attention. SBL is more common than PBL; this is a disseminated lymphoma with concomitant involvement of the skeleton. We review the clinical, imaging and pathologic features of bone lymphomas; and discuss therapeutic modalities as well as prognosis of these lymphomas in the era of immunochemotherapy.

Keywords: Bone lymphoma; Chemotherapy; Chimiothérapie; Diagnosis; Diagnostic; Lymphome osseux; Primary; Primitif; Radiotherapy; Radiothérapie; Secondaire; Secondary.

Publication types

  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Neoplasms* / classification
  • Bone Neoplasms* / diagnosis
  • Bone Neoplasms* / secondary
  • Bone Neoplasms* / therapy
  • Central Nervous System Neoplasms / prevention & control
  • Central Nervous System Neoplasms / secondary
  • Combined Modality Therapy
  • Diagnostic Imaging / methods
  • Female
  • Fractures, Spontaneous / etiology
  • Fractures, Spontaneous / surgery
  • Humans
  • Lymphoma, Non-Hodgkin* / diagnosis
  • Lymphoma, Non-Hodgkin* / pathology
  • Lymphoma, Non-Hodgkin* / therapy
  • Male
  • Organ Specificity
  • Prognosis
  • Radiotherapy / methods
  • Recurrence